{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6V05oJDA","lastupdate":"2022-11-21T00:00:00.000Z","update_date":"2022-11-21T00:00:00.000Z","lastModified":"Apr 7, 2025","active":1,"confidence_score":92,"confidence_score_reason":"markets, not claimed","urlname":"nanopass-technologies","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$eUEHwLCoeoiU8rgbSxy7lgZWNCJ0sLGz6WkmxPCj6iAdScFU4UyecK","name":"NanoPass Technologies","oneliner":"Intradermal Delivery Solutions","registrar":"512936212","website":"https://www.nanopass.com","careerspage":"","founded_month":4,"founded_year":2000,"formernames":[],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCVgNtRilCb2osZBAlAl7O3w","facebook":"https://www.facebook.com/Nanopass-Technologies-571265309657887","linkedin":"https://www.linkedin.com/company/3525547","instagram":"https://www.instagram.com/micronjetglobal"},"social":["https://www.youtube.com/channel/UCVgNtRilCb2osZBAlAl7O3w","https://www.linkedin.com/company/3525547","https://www.instagram.com/micronjetglobal","https://www.facebook.com/Nanopass-Technologies-571265309657887"],"flattenedsociallinks":"https://www.youtube.com/channel/UCVgNtRilCb2osZBAlAl7O3w|https://www.linkedin.com/company/3525547|https://www.instagram.com/micronjetglobal|https://www.facebook.com/Nanopass-Technologies-571265309657887","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":21,"patent":1,"raised":14100000,"stage":"C","public_stage":"C","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"NanoPass is where cutting-edge technology intersects with healthcare innovation. We pioneer revolutionary solutions in intradermal delivery, reshaping the landscape of therapeutic and medical aesthetic procedures using our proprietary technology towards a precise, safe, and efficient future. Our MicronJetTM intradermal delivery product platform has redefined the standard of care. Join us on our journey as we pave the way for a healthier, brighter future.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97289462905","country":null,"address":{"israeli":[{"id":"9b09a358-1499-49c0-ace1-ba7cc37fa8f6","city":"Ness Ziona","type":null,"address":"Golda Me'ir St 3, Ness Ziona, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"CiKom0s7AlljLA0iKk8zMvcuFDrqDz5mB1o673zKrGsLCyNB24nsIR","date":"Aug 4, 2024","link":"https://www.nanopass.com/news/press-releases/crescita-expands-medical-aesthetic-portfolio-with-micronjettm600-the-worlds-smallest-intradermal-delivery-device/","source":"www.nanopass.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"RGtCiuHQYx6dyErkoidGKXrltisnGliZEFcADe8NZl0yCVHOiOYKei","news_summary":"Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"84P886nT4YQwGAfW6F7ePO1UKxhwPdb72DOKCNDjhc1DSrrQDvwzDS","date":"Jul 14, 2024","link":"https://www.prnewswire.com/news-releases/nanopass-technologies-secures-awz-ventures-4m-investment-signaling-growth-and-innovation-in-intradermal-delivery-technology-302196740.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Investment, Management Changes","company":"NanoPass Technologies","layoffs":"Not mentioned","summary":"NanoPass Technologies, an innovator in intradermal delivery solutions, has secured a $4 million investment from Awz Ventures in a $6 million funding round. The funding will help NanoPass expand its commercial reach. The company has also appointed Daniel Levitats as its new CEO. NanoPass has developed the MicronJet platform, a next-generation technology for superior product delivery. The investment from Awz Ventures is part of its Active Capital strategy, providing NanoPass with multi-stage investment, mentorship, access to strategic partnerships, and preparation for future funding rounds and M&A opportunities.","partners":"Not mentioned","customers":"Not mentioned","investors":"Awz Ventures","confidence":9,"key_topics":["Investment","Intradermal Delivery","New CEO","MicronJet Platform","Awz Ventures"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$4 million","structured_issues":["Investment","Management Changes"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"PxCb9ciCb0cOSKHRqUthZoqpzHeEhbUYkxspaDz8AoaCtmSJgnWAXe","news_summary":"NanoPass Technologies Secures Awz Ventures' $4M Investment, Signaling Growth and Innovation in Intradermal Delivery Technology","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ca64383c-c14e-4267-8d4e-0e904fb15b79","date":"Feb 20, 2022","link":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_2110444_0_Txtetaxjxdshwhus8sp&did=1001402880","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Vaccine Technology","company":"Nanopass","layoffs":"Not mentioned","summary":"Israeli company Nanopass has received approval from the Israeli Ministry of Health to begin clinical trials for a coronavirus vaccine using a special subcutaneous injection technology. The product will be used in the clinical trial of the Biological Institutes vaccine, Brilife. The companys vaccination method reduces pain and also allows for an increase in the dosage of the vaccine reaching its target, effectively increasing the number of vaccine doses available to the state. The device developed by the company has already received FDA approval for subcutaneous injection and is also in trials for coronavirus in China. The technology can potentially be applied to other types of vaccines, including RNA vaccines.","partners":["Biological Institute","Brilife"],"customers":"Not mentioned","investors":["XT Fund","Viola Fund","IHCV","Alkam","WFD in New York","William Duell"],"confidence":9,"key_topics":["Vaccine","Coronavirus","Subcutaneous Injection","Clinical Trials","Funding"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"12.5 million dollars","structured_issues":"Investment, Partners","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment, Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"0VEBKVXfnz39eGPLqWklYtgVj6ld62eABfjUCWhaOxFgyXQ8cnpzGJ","news_summary":"ננופס תחל בניסוי במוצר שעשוי לשפר את יעילות חיסוני הקורונה","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ab32bd25-18d1-4f36-b396-cfd6ed201804","date":"Feb 7, 2022","link":"https://www.prnewswire.com/il/news-releases/nanopasss-intradermal-injection-platform-proven-to-sustain-covid-19-vaccine-antibodies-using-115-of-the-dose-reports-chinese-institute-of-medical-biology-301476501.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"COVID-19, vaccination, intradermal delivery","company":"NanoPass","layoffs":null,"summary":"A study conducted by IMB scientists and published by NanoPass has shown that intradermal COVID vaccination can effectively increase antibody levels. The study used NanoPasss MicronJet™600 device to administer a 1/15 dose of the vaccine intradermally, resulting in significant increases in antibody levels. The intradermal boost allowed for robust and sustained immunogenicity for at least six months. NanoPass CEO, Dr. Yotam Levin, commended the Chinese researchers for their work and highlighted the potential to multiply available vaccine doses by 15-fold. The study was a joint effort between NanoPass and YNC, with YNC supporting IMB. YNC CEO, Ni Jian, emphasized the importance of improving antibody levels and sustaining them for a longer time to combat COVID-19.","partners":"YNC","customers":null,"investors":null,"confidence":9,"key_topics":["Intradermal vaccination","MicronJet™600 device","Antibody levels","Collaboration with YNC","COVID-19"],"date_of_event":"2022-02-07","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2ucr69LSCRThaNwIDZB7Clg8N8N27MUXhrUyrBfvtgL7MicIuzwtpq","news_summary":"NanoPass's intradermal injection platform proven to sustain COVID-19 vaccine antibodies using 1/15 of the dose reports Chinese Institute of Medical Biology","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"731a5bea-066d-41c9-864f-8a91656b3685","date":"Jan 2, 2022","link":"https://techtime.co.il/2022/01/02/nanopass/?_atscid=7_134353_204082920_2081069_0_Txtetaxjxdshwhus8sp","source":"techtime.co.il","visible":1,"analysis":{"tags":"medical devices","company":"ננו-פאס (NanoPass)","layoffs":null,"summary":"NanoPass, an Israeli medical device company, has signed a strategic agreement with Korean MEMS manufacturer Micro2Nano to develop a mass production infrastructure for the worlds smallest medical needles. The needles, less than a millimeter in length, are produced using MEMS technology and have been approved by the FDA. The partnership with Micro2Nano will allow NanoPass to manufacture millions of units per year. The tiny needles enable painless intradermal injections and have clinical advantages over subcutaneous or intramuscular injections. NanoPass aims to use the needles for vaccinations, aesthetic treatments, allergy testing, and other medical procedures. The company has conducted over 60 clinical trials with approximately 7,500 patients. The FDA-approved needle is made of silicone and has a three-dimensional hollow pyramid structure.","partners":["Micro2Nano"],"customers":null,"investors":null,"confidence":9,"key_topics":["medical needles","MEMS technology","intradermal injection","clinical trials","applications"],"date_of_event":"2022-01-02","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"l4k6GE6A9ojV7ttBgxGjlUv5ypMFuC4G9Xgq8TUyv9sXeHoV4cGE58","news_summary":"ננו-פאס פיתחה את המחט הרפואית הזעירה בעולם - Techtime - חדשות אלקטרוניקה והייטק","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"14e85085-08aa-4c40-ba58-b518f43f2f5a","date":"Apr 25, 2016","link":"http://www.prnewswire.com/news-releases/west-makes-investment-in-nanopass-technologies-300256304.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"strategic investment","company":"West Pharmaceutical Services, Inc.","layoffs":null,"summary":"West Pharmaceutical Services, Inc. has announced a strategic investment in NanoPass Technologies Ltd. The investment will provide West with access to NanoPass knowledge and expertise in intradermal drug delivery and future collaboration opportunities. NanoPass will use the investment to advance its clinical development efforts and support the launch of its microneedle-based device for intradermal delivery of vaccines and drugs. West believes that intradermal drug delivery will be critical to the pharmaceutical and biotechnology industrys advancements in immunotherapy treatments. The partnership between West and NanoPass will enable the development of new vaccines and immunotherapies.","partners":["NanoPass Technologies Ltd."],"customers":null,"investors":"N/A","confidence":8,"key_topics":["strategic investment","intradermal drug delivery","microneedle-based device","partnership","clinical development"],"date_of_event":"April 25, 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"KdTOH6LmWnj6iL334ZvwRUSlIuAOmwFGV5U6zxtzVfajBoXpZMsLOm","news_summary":"West Makes Investment in NanoPass Technologies","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ed4af29b-593f-4562-bdb3-47c0ba74b595","date":"Sep 8, 2015","link":"https://www.prnewswire.com/news-releases/nanopass-technologies-to-supply-micronjet600-device-to-immune-design-for-use-in-zvex-based-oncology-immunotherapy-products-525620521.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"clinical supply agreement","company":"NanoPass Technologies Ltd.","layoffs":null,"summary":"NanoPass Technologies has entered into a clinical supply and support agreement with Immune Design for the supply of its microneedle delivery device for use with Immune Designs oncology immunotherapy products. The agreement provides Immune Design with non-exclusive access and supply of the device for its cancer immunotherapy programs globally. This collaboration marks NanoPasss entry into the growing field of cancer immunotherapy. The financial terms of the agreement were not disclosed.","partners":"Immune Design","customers":null,"investors":null,"confidence":8,"key_topics":["intradermal delivery","immunotherapies","oncology immunotherapy","microneedle delivery device","cancer immunotherapy"],"date_of_event":"September 8, 2015","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"GzUCnwaZbdDEDpOemyLYq9Jjj8eOrQn7GsHuxRg2WraRQjoOin6tEr","news_summary":"NanoPass Technologies to Supply MicronJet600™ Device to Immune Design for Use in ZVex-based Oncology Immunotherapy Products","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"13b2a358-4c7d-452c-81ec-4eb1ce7d219c","date":"May 6, 2015","link":"https://www.prnewswire.com/news-releases/nanopass-technologies-grants-an-exclusive-license-to-circassia-pharmaceuticals-for-use-of-its-micronjet600-device-in-allergy-testing-in-the-us-502750261.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"license agreement","company":"NanoPass Technologies Ltd.","layoffs":null,"summary":"NanoPass Technologies has entered into a license agreement with Circassia Pharmaceuticals for the supply of its microneedle delivery device, MicronJet600, for allergy testing in the US market. This agreement expands the collaboration between the two companies, as Circassia is already using the device in its allergy immunotherapy clinical studies. The financial terms of the agreement were not disclosed. NanoPass aims to improve usability, accuracy, and patient satisfaction in allergy testing through the use of its reliable device. The company sees potential in expanding its collaborations beyond vaccines into fields such as allergy and cancer. NanoPass has conducted multiple clinical studies and is backed by prominent investors. Circassia is a specialty biopharmaceutical company focused on the development and commercialization of allergy immunotherapy products.","partners":null,"customers":"Circassia Pharmaceuticals plc.","investors":null,"confidence":8,"key_topics":["intradermal delivery","vaccines","allergy testing","microneedle delivery device","license agreement"],"date_of_event":"May 6, 2015","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YviUCz1TaBqNmuCGslyfaAPaaVyyVdozU4kKzhZsd4Cr6fgOHLJGrQ","news_summary":"NanoPass Technologies Grants an Exclusive License to Circassia Pharmaceuticals, for use of its MicronJet600™ Device in Allergy Testing in the US","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8b8399e6-d8b2-4de6-af1c-0bd5895cfe72","date":"Nov 29, 2012","link":"https://www.prnewswire.com/news-releases/nanopass-technologies-grants-a-commercial-license-to-janssen-pharmaceuticals-inc-for-use-of-its-micronjet-device-181362571.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"license agreement","company":"NanoPass Technologies Ltd.","layoffs":null,"summary":"NanoPass Technologies has entered into a license agreement with Janssen Pharmaceuticals for its microneedle delivery device, MicronJet. The agreement grants Janssen an exclusive license to use the device in its seasonal influenza programs and options for additional vaccine fields. The financial terms were not disclosed. NanoPass sees this agreement as a significant milestone towards full market acceptance and believes that combining its device approach with Crucells vaccines has the potential to improve immunogenicity and reduce the dose of vaccination. The MicronJet device has proven efficacy and safety in multiple applications, including flu vaccines and insulin.","partners":["Janssen Pharmaceuticals, Inc."],"customers":null,"investors":null,"confidence":9,"key_topics":["MicronJet","vaccines","license agreement","immunogenicity","influenza"],"date_of_event":"November 29, 2012","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"RbfXfWIXmRm5xrGyHKjhbQfCKnm34VSKZ3NJk8wXvchlZuhK17BFUG","news_summary":"NanoPass Technologies Grants a Commercial License to Janssen Pharmaceuticals, Inc., for use of its MicronJet Device","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"1c9d85d9-90f4-4d5c-aacc-e0d3c9cae14c","date":"Jul 31, 2012","link":"https://en.globes.co.il/en/article-1000770617","source":"en.globes.co.il","visible":1,"analysis":{"tags":"financing","company":"NanoPass Technologies Ltd.","layoffs":null,"summary":"NanoPass Technologies has recently closed a new round of financing, led by Israel HealthCare Ventures. The amount raised was not disclosed but is believed to be several million dollars. The capital will be used to accelerate the market penetration of NanoPasss leading applications through additional licenses with pharmaceutical companies. As part of the financing, Dr. Hadar Ron of IHCV has joined NanoPasss board of directors. NanoPasss CEO, Dr. Yotam Levin, highlighted the companys technology for painless vaccine delivery and its ability to improve immune response with a reduced dose. IHCV managing partner, Dr. Ron, expressed the potential for the companys technology in other markets such as insulin delivery and aesthetics.","partners":null,"customers":null,"investors":"Israel HealthCare Ventures (IHCV)","confidence":9,"key_topics":["financing","market penetration","pharmaceutical companies","vaccine delivery","technology"],"date_of_event":"July 31, 2012","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"O22FoQmVeSN1cvyOvmVa5eHCFT3AWg3WOrqHAWumjVLddkmm707rCQ","news_summary":"Skin delivery solutions co NanoPass raises several million dollars","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"9c269d69-17f5-4c5b-90bb-b1c285804950","date":"Sep 15, 2011","link":"https://pipelinereview.com/index.php/2011091544916/More-News/NanoPass-Technologies-Grants-a-License-to-its-Intradermal-Delivery-Device-to-Circassia-for-Use-in-Multiple-Allergy-Vaccine-Fields.html","source":"pipelinereview.com","visible":1,"analysis":{"tags":"license agreement","company":"NanoPass Technologies","layoffs":null,"summary":"NanoPass Technologies has granted a license to its intradermal delivery device, MicronJet, to Circassia for use in multiple allergy vaccine fields. The license agreement will allow Circassia to use the device with its cat and ragweed allergy therapies, which will enter phase III clinical trials in 2012. The financial terms of the agreement were not disclosed. NanoPass Technologies sees this agreement as a significant fit between its device and Circassias patients needs. The company plans to make MicronJet a valuable component of its product offerings and has received positive feedback from patients and clinicians. NanoPass Technologies was founded by Dr. Shuki Yeshurun and is backed by prominent Israeli and US investors.","partners":"Circassia","customers":null,"investors":null,"confidence":8,"key_topics":["MicronJet","intradermal delivery device","license agreement","Circassia","allergy vaccine fields"],"date_of_event":"2011-09-15","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"cTXmkbLwRwdkleOMq8yTeQ3FzEkzbMzCQueOWY4iCwANbsIqC8CEeV","news_summary":"The Biologics News and Reports Portal","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"53e0a86f-7092-4dd9-86fd-1755aca54ef8","date":"Aug 31, 2009","link":"https://www.idri.org/idri-use-nanopass-micorneedle-technology/","source":"www.idri.org","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"bfmeaZYevP0ozDVxYfYzigNOdcKGq9TpM11sCzjtw3jNl6AbsXHK1T","news_summary":"https://www.idri.org/idri-use-nanopass-micorneedle-technology/","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"49b259ca-bc0f-4b47-ad78-5eb23e25afcd","date":"Feb 26, 2007","link":"http://www.nanooze.org/hate-needles-now-nanopass-needles-offer-painless-vaccinations/","source":"www.nanooze.org","visible":1,"analysis":{"tags":"nanotechnology, needles","company":"NanoPass Technologies","layoffs":null,"summary":"Israeli startup NanoPass Technologies has developed a nanotechnology product called the NanoPass needle, which aims to deliver pain-free injections by avoiding nerve endings. The needles tips are made of pure silicone crystals and measure less than one-micrometer in diameter. The company claims the technology is easier to administer and more comfortable for patients. The article discusses the potential impact of NanoPass needles on the vaccination process.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["NanoPass Technologies","nanotechnology","needles","vaccination","pain-free"],"date_of_event":"February 26, 2007","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YnSqrYOma5vD84Qb1y6xPYuSyVkqjtxs67K0dsRz4ZLjaeS5y928VX","news_summary":"Hate Needles? Now NanoPass needles offer painless vaccinations...","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"fb963ec7-f135-4e79-85a3-20e45d462f43","date":"Feb 14, 2007","link":"https://en.globes.co.il/en/article-1000183222","source":"en.globes.co.il","visible":1,"analysis":{"tags":"financing round","company":"NanoPass Technologies Ltd.","layoffs":null,"summary":"NanoPass Technologies Ltd. has closed its first financing round, raising $6.5 million from Ofer Hi Tech Ltd., WFD Ventures LLC, and D-Partners. The company will use the funds to complete clinical development and launch its product line. NanoPass has developed a platform for intradermal drug delivery using micro-pyramid devices. It was founded in 2000 and has raised a total of $1.6 million to date. The financing round marks a positive growth for the company.","partners":null,"customers":null,"investors":["Ofer Hi Tech Ltd.","WFD Ventures LLC","D-Partners"],"confidence":9,"key_topics":["financing round","clinical development","product launch","intradermal drug delivery","micro-pyramid devices"],"date_of_event":"February 14, 2007","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":6500000,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CDmdekKUDEVSaH2TQsr2h93yf0FN7pGP7pslIJQf8kplsJHeJeewMg","news_summary":"Intradermal drug delivery co NanoPass raises $6.5m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":14,"techcommunityinvolvement":null,"mediagallery":[{"id":"xBUjmqopm47It17e9Jrha2197zHLs4RcFXYbSU7ik0j2yeHjRMbu5M","timestamp":"2025-04-07 12:15:26.000000","resources_type":2,"resources_title":"How to Use MicronJet™ Intradermal Delivery Device?","resources_file_name":"EclGoP95f_I","alt":"How to Use MicronJet™ Intradermal Delivery Device? logo","imageurl":"https://img.youtube.com/vi/EclGoP95f_I/0.jpg","url":"http://youtu.be/EclGoP95f_I"},{"id":"zDcibCQFLj7U09BHpMy7FdxVYtVOy3Wtlyqb3zRjLPSKSVx3iqdyhU","timestamp":"2025-04-07 12:15:26.000000","resources_type":2,"resources_title":"MicronJet by NanoPass","resources_file_name":"wKohUBeseY8","alt":"MicronJet by NanoPass logo","imageurl":"https://img.youtube.com/vi/wKohUBeseY8/0.jpg","url":"http://youtu.be/wKohUBeseY8"},{"id":"c2c73683-6b52-4968-9f97-669b6f29cab8","timestamp":"2018-04-23 07:27:09.000000","resources_type":2,"resources_title":"How to perform a MicronJet600 injection","resources_file_name":"WpEQ0Frq1bw","alt":"How to perform a MicronJet600 injection logo","imageurl":"https://img.youtube.com/vi/WpEQ0Frq1bw/0.jpg","url":"http://youtu.be/WpEQ0Frq1bw"}],"tags":["cosmetics","medical-equipment","diabetes","pharma-companies","drug-delivery","medical-technologies","pain-free","doctors","hospitals","healthcare-providers","vaccines","nanotechnology"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvc554IDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["MicronJet"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":6,"lastfunding":"$6M","totalrounds":6,"fundingstage":"C","totalfunding":"$14.1M","publicinvestors":6,"lastpublicfunding":6000000,"totalpublicrounds":6,"totalpublicfunding":14100000},"team":[{"name":"Yotam Levin","email":"yotam@nanopass.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN7HhasIDA","bounced":false,"claimed":1,"founder":0,"urlname":"yotam-levin-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAsd_26QgM","position":"President of Innovation","last_name":"Levin","claimtoken":"QtqJtWsrIsNBtJ5nDUfnqLCOrdJelil1vccSeRc1fdDN8MK9TRVC4R","first_name":"Yotam","picturekey":null,"claimeddate":"2025-04-07","linkedinurl":"https://www.linkedin.com/in/yotam-levin-b04aaa/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2025-04-07 11:41:56.000000","initials":"YL","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Daniel Levitats","email":"daniel@nanopass.com","phone":"","gender":"Male","userid":"NA5DF0CcqEAYGTy01Eh7RAC65L60KV3n35W8OfFImMcwFtdjTJtOeD","bounced":false,"claimed":null,"founder":0,"urlname":"daniel-levitats","visible":1,"memberid":"biXi7dp6ZQqqHmb3LLWkIa3sq5o0s2Co6f4Q40oXJ7UTFfK1Mo2TYV","position":"CEO","last_name":"Levitats","claimtoken":"ZX0FAhvkw8V1SdSirfy1xLUzvgrHhk3l85RHv264GnEmr3v7ShAs3u","first_name":"Daniel","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/daniel-levitats/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-07-17 12:12:45.000000","initials":"DL","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shuki Yeshurun","email":"shuki@nanopass.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylPEIDA","bounced":false,"claimed":0,"founder":1,"urlname":"shuki-yeshurun-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICA3o6d0ggM","position":"Founder","last_name":"Yeshurun","claimtoken":"G8EcUIAOP8v32Ivo1BIiNBKdw6kjL1S8cbDTEOFC0ebKqmreBGkM8h","first_name":"Shuki","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shuki-yeshurun-b8a3027/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-11-21 15:23:20.000000","initials":"SY","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Efrat Kochba","email":"efrat@nanopass.com","phone":"","gender":"Female","userid":"blT5K6tWICpwdhwiZ3rkm0pqnKzIfhlhnd81hOqvRDJCRcojfrLxUa","bounced":false,"claimed":null,"founder":0,"urlname":"efrat-kochba","visible":1,"memberid":"Tlqv0RDEb64Crg9zQKiY1JZvhLvrwb5OUJLXOKS3JONJHyZlvaZqqK","position":"Medical Director","last_name":"Kochba","claimtoken":"mcaplD8BGfP3SFDqQTWQoSbnwGxFximL8f5PmduDhcWzCLPVSCXKjx","first_name":"Efrat","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/efrat-kochba-024a9511/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-11-21 15:24:30.000000","initials":"EK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Yoav  Hamisha","email":"yoav@nanopass.com","phone":"","gender":"Male","userid":"kzPRaif418Mra6wDnuHad5BRrkrx3zzNZd46fx7sUZRilsnw90lceo","bounced":false,"claimed":null,"founder":0,"urlname":"yoav-hamisha","visible":1,"memberid":"iBsl12acw30wqCYSztBq67LpaOA1xIf5B1GQIkDShxqamh3YEYhS9h","position":"Director Of R&D and Operations","last_name":"Hamisha","claimtoken":"proR8jDZrra23zyQWWYP2R6sNoRhvt4dRzW8aVS66jJPXUupoNDkB6","first_name":"Yoav ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yoav-hamisha-a966ba2/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-11-21 15:26:44.000000","initials":"YH","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2019-10-30T00:00:00.000Z","crunchbaseid":"nanopass-technologies","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Raz Zohar","creator_email":"raz@platterz.ca","createdate":"2014-09-09T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Ayelet Beazley","affiliatedOrganizations":null,"timeline":[{"id":"0mHHizncumitWA72HBiaknCljFj4VC4xwNbm6TNabWGoCKX8fIyjId","date":"Jul 2024","amount":"$6M","source":"https://www.prnewswire.com/news-releases/nanopass-technologies-secures-awz-ventures-4m-investment-signaling-growth-and-innovation-in-intradermal-delivery-technology-302196740.html","eventtype":"FundingRoundEvent","investment":[{"name":"Awz Ventures","type":"Investor","amount":4000000,"hidden":false,"country":"Canada","fullurl":"/investor_page/awz-ventures","logokey":"$D93ARLygH0jZmDfrNi8qKth0nmUkyGScdVj0G2AdKTFvZBg0BTgCCJ","tagline":null,"urlname":"/investor_page/awz-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4I3FlMMIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0UeWPWt8b5lyf3WxlIOrrFg68M51InLiLbvj0jq7jkbee3Ae8iYp2Y","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$D93ARLygH0jZmDfrNi8qKth0nmUkyGScdVj0G2AdKTFvZBg0BTgCCJ","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":6000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD4uabgCww","date":"May 2019","amount":"Undisclosed","source":"Founder - See Notes","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkw_WcCww","date":"Apr 2016","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"West Pharmaceutical Services","type":"Multinational","amount":0,"hidden":false,"country":"United States","fullurl":"/mnc_page/west-pharmaceutical-services","logokey":"$de69BaEwHLvO8EdmKakgYEyWvuWcFdmo29yHpNMmnyJ06BU5ib8RDj","tagline":"Pharmaceuticals","urlname":"/mnc_page/west-pharmaceutical-services","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMqXhp8KDA","fundingtype":"Multinational","leadpartner":null,"investmentid":"068c43ef-727b-407d-8738-a08678aafa0f","fundingsubtype":null,"investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$de69BaEwHLvO8EdmKakgYEyWvuWcFdmo29yHpNMmnyJ06BU5ib8RDj","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODElY3aCAw","date":"Jul 2012","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Israel HealthCare Ventures (IHCV)","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/israel-healthcare-ventures-ihcv","logokey":null,"tagline":"","urlname":"/investor_page/israel-healthcare-ventures-ihcv","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEv6ChCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"899de72e-c925-4049-b139-25b5065aa19e","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODk_IXHCww","date":"Feb 2007","amount":"$6.5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"WFD Ventures LLC","type":"Other","amount":0,"hidden":false,"country":"Unknown location","fullurl":"/company_page/wfd-ventures-llc","logokey":null,"tagline":"","urlname":"/company_page/wfd-ventures-llc","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODkzKu5Cgw","fundingtype":"Other","leadpartner":null,"investmentid":"11a6d8f7-1a7c-4ec1-9ac2-17b90decacf1","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","leadcaption":"","followupcaption":""},{"name":"Ofer Hi-Tech","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/ofer-hi-tech","logokey":"$0rBNJU9mqQvqPE0FtcQ5nmHTAxJcVznAYlWLDGPkYLtnGO1VXVjq4n.png","tagline":"","urlname":"/investor_page/ofer-hi-tech","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk8IGkCww","fundingtype":"Angel Group","leadpartner":null,"investmentid":"7d16203f-0735-4a00-97c4-f2f6f0fbe0dd","fundingsubtype":"Angel Group","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$0rBNJU9mqQvqPE0FtcQ5nmHTAxJcVznAYlWLDGPkYLtnGO1VXVjq4n.png","leadcaption":"","followupcaption":"Follow on "},{"name":"Undisclosed Investor(s)","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"MR8zRmatAGFGdnnXbdw2fvrgAbnYB73DuCyERdSDLK6cVdz1zls4rx","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":6500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE1cOwCQw","date":"Apr 2000","amount":"$1.6M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Ofer Hi-Tech","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/ofer-hi-tech","logokey":"$0rBNJU9mqQvqPE0FtcQ5nmHTAxJcVznAYlWLDGPkYLtnGO1VXVjq4n.png","tagline":"","urlname":"/investor_page/ofer-hi-tech","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk8IGkCww","fundingtype":"Angel Group","leadpartner":null,"investmentid":"bf966bc8-d203-4e1e-ada1-513ada4cb6d0","fundingsubtype":"Angel Group","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$0rBNJU9mqQvqPE0FtcQ5nmHTAxJcVznAYlWLDGPkYLtnGO1VXVjq4n.png","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"4/2000","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"NanoPass Technologies","logourl":"https://storage.googleapis.com/clean-finder-353810/$eUEHwLCoeoiU8rgbSxy7lgZWNCJ0sLGz6WkmxPCj6iAdScFU4UyecK","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$eUEHwLCoeoiU8rgbSxy7lgZWNCJ0sLGz6WkmxPCj6iAdScFU4UyecK","seoabout":"NanoPass is where cutting-edge technology intersects with healthcare innovation. We pioneer revolutionary solutions in intradermal delivery, reshaping the ...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":5,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Silicon","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvc554IDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA>Silicon#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvc554IDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA|2:>TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA/Silicon#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvc554IDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"},{"title":"Drug Delivery","key":"0-0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drug Delivery"}]},{"title":"Medical Devices","key":"0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-1-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]},{"title":"Healthcare","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Materials & Substances","key":"0-0","path":"TechnologyClassificationModel>Materials & Substances","children":[{"title":"Silicon","key":"0-0-0","path":"TechnologyClassificationModel>Materials & Substances>Silicon"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Silicon","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvc554IDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development","Drug Delivery","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Materials & Substances","Silicon"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"0mHHizncumitWA72HBiaknCljFj4VC4xwNbm6TNabWGoCKX8fIyjId","date":"Jul 2024","amount":"$6M","source":"https://www.prnewswire.com/news-releases/nanopass-technologies-secures-awz-ventures-4m-investment-signaling-growth-and-innovation-in-intradermal-delivery-technology-302196740.html","eventtype":"FundingRoundEvent","investment":[{"name":"Awz Ventures","type":"Investor","amount":4000000,"hidden":false,"country":"Canada","fullurl":"/investor_page/awz-ventures","logokey":"$D93ARLygH0jZmDfrNi8qKth0nmUkyGScdVj0G2AdKTFvZBg0BTgCCJ","tagline":null,"urlname":"/investor_page/awz-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4I3FlMMIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0UeWPWt8b5lyf3WxlIOrrFg68M51InLiLbvj0jq7jkbee3Ae8iYp2Y","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$D93ARLygH0jZmDfrNi8qKth0nmUkyGScdVj0G2AdKTFvZBg0BTgCCJ","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":6000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD4uabgCww","date":"May 2019","amount":"Undisclosed","source":"Founder - See Notes","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkw_WcCww","date":"Apr 2016","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"West Pharmaceutical Services","type":"Multinational","amount":0,"hidden":false,"country":"United States","fullurl":"/mnc_page/west-pharmaceutical-services","logokey":"$de69BaEwHLvO8EdmKakgYEyWvuWcFdmo29yHpNMmnyJ06BU5ib8RDj","tagline":"Pharmaceuticals","urlname":"/mnc_page/west-pharmaceutical-services","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMqXhp8KDA","fundingtype":"Multinational","leadpartner":null,"investmentid":"068c43ef-727b-407d-8738-a08678aafa0f","fundingsubtype":null,"investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$de69BaEwHLvO8EdmKakgYEyWvuWcFdmo29yHpNMmnyJ06BU5ib8RDj","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODElY3aCAw","date":"Jul 2012","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Israel HealthCare Ventures (IHCV)","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/israel-healthcare-ventures-ihcv","logokey":null,"tagline":"","urlname":"/investor_page/israel-healthcare-ventures-ihcv","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEv6ChCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"899de72e-c925-4049-b139-25b5065aa19e","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODk_IXHCww","date":"Feb 2007","amount":"$6.5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"WFD Ventures LLC","type":"Other","amount":0,"hidden":false,"country":"Unknown location","fullurl":"/company_page/wfd-ventures-llc","logokey":null,"tagline":"","urlname":"/company_page/wfd-ventures-llc","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODkzKu5Cgw","fundingtype":"Other","leadpartner":null,"investmentid":"11a6d8f7-1a7c-4ec1-9ac2-17b90decacf1","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","leadcaption":"","followupcaption":""},{"name":"Ofer Hi-Tech","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/ofer-hi-tech","logokey":"$0rBNJU9mqQvqPE0FtcQ5nmHTAxJcVznAYlWLDGPkYLtnGO1VXVjq4n.png","tagline":"","urlname":"/investor_page/ofer-hi-tech","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk8IGkCww","fundingtype":"Angel Group","leadpartner":null,"investmentid":"7d16203f-0735-4a00-97c4-f2f6f0fbe0dd","fundingsubtype":"Angel Group","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$0rBNJU9mqQvqPE0FtcQ5nmHTAxJcVznAYlWLDGPkYLtnGO1VXVjq4n.png","leadcaption":"","followupcaption":"Follow on "},{"name":"Undisclosed Investor(s)","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"MR8zRmatAGFGdnnXbdw2fvrgAbnYB73DuCyERdSDLK6cVdz1zls4rx","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":6500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE1cOwCQw","date":"Apr 2000","amount":"$1.6M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Ofer Hi-Tech","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/ofer-hi-tech","logokey":"$0rBNJU9mqQvqPE0FtcQ5nmHTAxJcVznAYlWLDGPkYLtnGO1VXVjq4n.png","tagline":"","urlname":"/investor_page/ofer-hi-tech","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk8IGkCww","fundingtype":"Angel Group","leadpartner":null,"investmentid":"bf966bc8-d203-4e1e-ada1-513ada4cb6d0","fundingsubtype":"Angel Group","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$0rBNJU9mqQvqPE0FtcQ5nmHTAxJcVznAYlWLDGPkYLtnGO1VXVjq4n.png","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}